Stock listing
Surenano Science Ltd
Selected listing: SURNF · OTC · USD · US
Surenano Science Ltd (OTC:SURNF), Health Technology. Latest release Apr 24, 2026: SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies…
- Ticker
- OTC:SURNF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- OTC
- Currency
- USD
About Surenano Science Ltd
The company focuses on innovative solutions in the nanotechnology sector. Surenano aims to leverage advanced materials to enhance various applications across industries.
Latest news from Surenano Science Ltd
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
April 24, 2026
SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development
February 23, 2026
SureNano Announces Stock Option Grant
December 12, 2025
SureNano Announces Closing of $1,250,000 Private Placement
December 10, 2025
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
November 19, 2025
Research Surenano Science Ltd
Surenano Science Ltd company profile
View the public company page for Surenano Science Ltd on 6ix.
Surenano Science Ltd news
Read company news and market updates connected to Surenano Science Ltd.
Surenano Science Ltd investor events
Find investor webinars, events, and replay context for Surenano Science Ltd.